RSV Clinical Trials: Shaping the Future of Respiratory Healthcare
In the search for medical breakthroughs, FOMAT Medical Research is committed to understanding and treating Respiratory Syncytial Virus (RSV). Through our clinical trials, we aim to develop new treatments and prevention methods for RSV.
What is Respiratory Syncytial Virus (RSV)?
Definition and RSV in Healthcare
Respiratory Syncytial Virus (RSV) is a common virus that causes respiratory tract infections. It is particularly severe in infants, the elderly, and those with weakened immune systems.
How is RSV spread?
RSV is spread through droplets when an infected person coughs or sneezes. It can also be spread by touching a surface contaminated with the virus and then touching your face.
Symptoms of RSV Infections
RSV infections often present with symptoms similar to a cold, including:
- Runny nose
- Loss of appetite
- Coughing
- Sneezing
- Fever
- Wheezing In severe cases, it can lead to bronchiolitis or pneumonia, especially in young children and the elderly.
Risk Factors
Some people are more at risk of severe RSV infection:
- Infants under 6 months old
- Premature infants
- Children with chronic lung disease or congenital heart disease
- Immunocompromised individuals
- Adults over 65 years old
- People with compromised immune systems
Why Clinical Trials are Important for RSV Research
Why Clinical Trials are Important for RSV Research
- Test the safety and efficacy of new antiviral drugs and vaccines
- Develop innovative treatments to reduce the severity of RSV infections
- Improve preventative measures to protect high-risk populations
By joining RSV trials, you contribute to research that can lead to big medical breakthroughs. Participants get access to the latest treatments and help public health
By participating in RSV trials, individuals contribute to groundbreaking research that can lead to significant medical advancements. Participants often gain access to the latest treatments and play a vital role in improving public health
Our Active Clinical Research Studies
-
Respiratory Syncytial Virus (RSV) Pediatric Study
We’re conducting a study to explore a new option for children with respiratory syncytial virus (RSV). This research aims to better understand how it can support recovery and overall health.
Read more
Criteria & Qualifications: • Must be under 18 years old.
• Diagnosed with RSV.
• May have health factors like certain medical conditions.
Compensation: Contact us for more information -
Respiratory Syncytial Virus (RSV) Trial
We’re conducting a study to evaluate a new treatment for adults with acute respiratory syncytial virus (RSV) infection. The goal is to understand how this treatment may help reduce symptoms faster and improve health outcomes.
Read more
Criteria & Qualifications: • Must be 18 years or older.
• Diagnosed with acute RSV infection.
• Exhibits risk factors such as age 60+, chronic lung diseases, or cardiovascular conditions.
Compensation: Contact us for more information -
Device for COVID, Flu and RSV
Help us improve understanding of respiratory infections like COVID-19, Flu A, Flu B, and RSV. Criteria & Qualifications: • Must have symptoms such as cough, fatigue, or sore throat that started within the last 7 days. • Must not currently have nasal trauma (e.g., nosebleeds) or have used nasal rinses recently. • Must not be undergoing treatment for COVID-19 or flu within the past 14 days. Compensation: Contact us for more information.
Read more -
Respiratory Syncytial Virus (RSV)
Participate in an RSV vaccine study to combat lung infections. Help us understand vaccine effects in diverse health conditions. Eligibility criteria apply.
Read more
Criteria & Qualifications: • Must be 18 years or older and diagnosed with RSV within the last 5 days.
• Experiencing new or worsening symptoms like cough or shortness of breath within 5 days before randomization.
• Either aged 65+, or have chronic lung disease, heart failure, or an immunosuppressive condition.
Compensation: Contact us for more information
Frequently Asked Questions
Who is FOMAT Medical Research?
FOMAT Medical Research is California’s largest research site network, dedicated to advancing clinical research and improving patient outcomes. With multiple research sites and a passion for innovation through diversity, FOMAT Medical Research partners with industry Sponsors and CROs to speed up the development of new treatments across multiple therapeutic areas. FOMAT is a founding member of hyperCORE International, a network of fully professionalized research site organizations.
FOMAT's Commitment to RSV Research
FOMAT Medical Research is driving RSV research. Our expertise in conducting clinical trials enables us to make significant strides in understanding and combating this virus. We invite individuals, sponsors, and healthcare professionals to join us in our mission to advance RSV research.
Meet Our Experts
